Opdivo nivolumab: Phase II data

Top-line data from the open-label, international Phase II CheckMate -275 trial in 270 patients with metastatic or unresectable urothelial cancer who have progressed or recurred following treatment with a platinum-containing regimen in the

Read the full 338 word article

User Sign In